A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.
13h
Hosted on MSNAfrican Americans diagnosed with pancreatic cancer in advanced stages: 'Changes outlook on life'Severe abdominal pain was one of the first signs of pancreatic cancer for Paula Rowland. She ignored it for months. After ...
A new blood test has been found to detect early stage pancreatic cancer with 85% accuracy when used alongside a carbohydrate antigen 19-9 test, according to a study published Feb. 12 in Science ...
17h
Hosted on MSNBlood Test for Early Pancreatic Cancer Shows PromiseHe noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...
Most pancreatic cancer isn’t caught until it’s late stage — a new blood test could change that
The American Cancer Society estimates that 67,400 Americans will be diagnosed with pancreatic cancer this year and nearly ...
Dr. Waqqas Tai is a cancer doctor who often shares health advice online. He recently revealed what the five most "lethal" ...
Giri's posthumous organ donation has given him a new life." The liver was transported from the airport to the local hospital within just 15 minutes through a "green corridor", said Sandipan Arya ...
The organ, which filters blood, metabolises nutrients and helps digest food, was sent to Indore in Madhya Pradesh from Goa on Thursday evening on a regular flight operated by a private airline.
Blood from 19 PDAC (Stage II-III), 20 chronic pancreatitis (CP), 1 other pancreatic cancer (PC; defined as non-PDAC; Stage II-III), and 13 dyspeptic ulcer (DYS) patients, as well as 7 healthy controls ...
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, P. R. China ...
EVEREST-2: A seamless phase 1/2 study of A2B694, a logic-gated Tmod chimeric antigen receptor T-cell (CAR T) therapy, in patients with pancreatic cancer (PANC) or other mesothelin (MSLN)-expressing ...
Cohort-level patient-derived organoid assays and prediction of clinical trial outcomes in PDAC. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results